A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

PHASE3TerminatedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

April 7, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
Keratosis, Actinic
Interventions
DRUG

MAL Cream

No intervention will be administered as a part of this study. Participants who received MAL cream in RD.06.SPR.112199 study will be rolled over in the study.

DRUG

Vehicle cream

No intervention will be administered as a part of this study. Participants who received vehicle cream in RD.06.SPR.112199 study and achieved complete response, will be rolled over in the study.

Trial Locations (53)

10010

Galderma Investigational Site, New York

10022

Galderma Investigational Site, New York

10075

Galderma Investigational Site, New York

11209

Galderma Investigational Site, Brooklyn

15213

Galderma Investigational Site, Pittsburgh

18249

Galderma Investigational Site, Sugarloaf

19103

Galderma Investigational Site, Philadelphia

24501

Galderma Investigational Site (Site#8057), Lynchburg

26505

Galderma Investigational Site (Site#8725), Morgantown

28277

Galderma Investigational Site (Site#8566), Charlotte

29407

Galderma Investigational Site (Site#8777), Charleston

31904

Galderma Investigational Site (Site#8667), Columbus

32771

Galderma Investigational Site (Site#8529), Sanford

33028

Galderma Investigational Site (Site#8734), Pembroke Pines

33162

Galderma Investigational Site (Site#8765), North Miami Beach

33401

Galderma Investigational Site (Site#8126), West Palm Beach

33461

Galderma Investigational Site (Site#8769), Lake Worth

33936

Galderma Investigational Site (8770), Lehigh Acres

34209

Galderma Investigational Site (Site#8479), Bradenton

37215

Galderma Investigational Site (Site#8207), Nashville

40241

Galderma Investigational Site (Site#8724), Louisville

43016

Galderma Investigational Site (Site#8595), Dublin

48346

Galderma Investigational Site (Site#8574), Clarkston

49085

Galderma Investigational Site (Site#8757), Saint Joseph

55410

Galderma Investigational Site, Edina

60561

Galderma Investigational Site (Site#8838), Darien

63141

Galderma Investigational Site, St Louis

68144

Galderma Investigational Site (Site#8048), Omaha

72916

Galderma Investigational Site (Site#8447), Fort Smith

75034

Galderma Investigational Site (Site#8664), Frisco

77056

Galderma Investigational Site (Site#8576), Houston

77845

Galderma Investigational Site (Site#8139), College Station

78660

Galderma Investigational Site (Site#8546), Pflugerville

78759

Galderma Investigational Site (Site#8076), Austin

80111

Galderma Investigational Site (Site#8440), Greenwood Village

80210

Galderma Investigational Site (Site#8778), Denver

83704

Galderma Investigational Site (Site#8755), Boise

83713

Galderma Investigational Site, Boise

84101

Galderma Investigational Site (Site#8761), Salt Lake City

84117

Galderma Investigational Site (Site#8672), Salt Lake City

84790

Galderma Investigational Site (Site#8776), St. George

87102

Galderma Investigational Site (Site#8759), Albuquerque

92024

Galderma Investigational Site (Site#8577), Encinitas

92708

Galderma Investigational Site (Site#8636), Fountain Valley

94538

Galderma Investigational Site (Site#8224), Fremont

97210

Galderma Investigational Site (Site#8212), Portland

98168

Galderma Investigational Site (Site#8779), Seattle

99202

Galderma Investigational Site (Site#8760), Spokane

Galderma Investigational Site 2(Site#8039), Spokane

01915

Galderma Investigational Site (Site#8208), Beverly

03801

Galderma Investigational Site 9Site#8420), Portsmouth

10029-6501

Galderma Investigational Site, New York

00705

Galderma Investigational Site (Site#8231), Aibonito

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY